These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 199333)

  • 1. Plasma adenosine 3',5'-cyclic monophosphate: dose-response to injected bovine parathyroid hormone in man.
    Lewin IG; Hendy GN; Papapoulos SE; Tomlinson S; O'Riordan JL
    Calcif Tissue Res; 1977 May; 22 Suppl():332-5. PubMed ID: 199333
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible resistance to the renal action of parathyroid hormone in man.
    Tomlinson S; Hendy GN; Pemberton DM; O'Riordan JL
    Clin Sci Mol Med; 1976 Jul; 51(1):59-69. PubMed ID: 181194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.
    Hendy GN; Tomlinson S; O'Riordan JL
    Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood levels of parathyroid hormone, calcitonin and cyclic adenosine monophosphate in diabetes mellitus].
    Mosim VI; Iagoda AV; Grosman BE
    Ter Arkh; 1980; 52(8):80-3. PubMed ID: 6266062
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasma 1.25 (OH)2D and PTH levels and urinary cyclic AMP response to exogenous PTH in PHP during childhood (author's transl)].
    Seino Y; Ishida M; Shimotsuji J; Ishii T; Matsuda S
    Horumon To Rinsho; 1979 Aug; 27(8):879-84. PubMed ID: 226296
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal responsiveness to parathyroid hormone in a case of nonfamilial hypophosphatemic osteomalacia.
    de Backer M; de Nutte N; Verbeelen D; Ducobu J; Six R; Corvilain J
    Klin Wochenschr; 1980 Jul; 58(13):689-94. PubMed ID: 6255225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone.
    Fujita T; Nomura M; Okajima S; Furuya H
    J Clin Endocrinol Metab; 1980 May; 50(5):927-31. PubMed ID: 6246136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal plasma-1,25-(OH)2-vitamin-D concentrations in nutritional osteomalacia.
    Eastwood JB; de Wardener HE; Gray RW; Lemann JL
    Lancet; 1979 Jun; 1(8131):1377-8. PubMed ID: 87836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary hyperparathyroidism: clinical and laboratory aspects (author's transl)].
    Furukawa Y
    Horumon To Rinsho; 1981 Nov; 29(11):1331-6. PubMed ID: 6280906
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of exogenous parathyroid hormone on plasma and urinary adenosine 3', 5'-cyclic monophosphate in man.
    Tomlinson S; Barling PM; Albano JD; Brown BL; O'Riordan JL
    Clin Sci Mol Med; 1974 Nov; 47(5):481-92. PubMed ID: 4373203
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.
    Forte LR; Nickols GA; Anast CS
    J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to vitamin D and parathyroid hormone.
    Moses AM
    N Engl J Med; 1978 Aug; 299(8):423-4. PubMed ID: 209328
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal cyclic adenosine monophosphate: an accurate index of parathyroid function.
    Drezner MK; Neelon FA; Curtis HB; Lebovitz HE
    Metabolism; 1976 Oct; 25(10):1103-12. PubMed ID: 184364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible resistance to the renal action of parathyroid hormone in human vitamin D deficiency.
    Lewin IG; Papapoulos SE; Hendy GN; Tomlinson S; O'Riordan JL
    Clin Sci (Lond); 1982 Apr; 62(4):381-7. PubMed ID: 6279352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP responses to parathyroid hormone and glucagon during lithium treatment.
    Waller DG; Albano JD; Millar JG; Polak A
    Clin Sci (Lond); 1984 May; 66(5):557-9. PubMed ID: 6323091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia.
    Mosekilde L; Christensen MS; Lund B; Sorensen OH; Melsen F
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):559-65. PubMed ID: 576530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: The effects of exogenous parathyroid hormone on circulating adenosine 3':5' monophosphate in man.
    Tomlinson S; Albano JD; Barling PM; Brown BL; O'Riordan JL
    Clin Sci Mol Med; 1974 Feb; 46(2):10P-11P. PubMed ID: 4361482
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoparathyroidism: a possible cause of osteomalacia .
    Drezner MK; Neelon FA; Jowsey J; Lebovitz HE
    J Clin Endocrinol Metab; 1977 Jul; 45(1):114-22. PubMed ID: 874058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25(OH)2D3 is not the only D metabolite involved in the pathogenesis of osteomalacia.
    Rasmussen H; Baron R; Broadus A; DeFronzo R; Lang R; Horst R
    Am J Med; 1980 Sep; 69(3):360-8. PubMed ID: 6251721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.